Hyro has closed a $45 million growth round led by Healthier Capital to accelerate its AI agent platform that automates patient communications across voice, chat, mobile and web channels for health systems and payers.
Glimpse:
The funding will allow Hyro to scale its enterprise-ready conversational AI agents which resolve up to 85 % of routine patient interactions and integrate deeply with EHRs and CRMs. The platform is already deployed across more than 45 health systems and supports over 30 million patients. The round brings Hyro’s total funding to around $95 million.
New York-based Hyro, a specialist in healthcare-native conversational AI, announced a $45 million strategic growth funding round led by Healthier Capital, with participation from Norwest, Define Ventures, ServiceNow Ventures and new strategic investments from Bon Secours Mercy Health (one of Hyro’s long-time clients).
The new capital will enable Hyro to accelerate the development of its administrative, operational and clinical AI agents for digital and voice channels. These agents are designed to automate large volumes of routine interactions, such as scheduling, routing, registration and prescription refills, while integrating securely with EMR systems like Epic and CRMs.
Hyro’s solution is already in use across more than 45 major health systems in the U.S., supporting engagements with over 30 million patients. Its hybrid architecture combines large language models (LLMs) with proprietary knowledge graphs and small language models (SLMs) to ensure reliability, healthcare-compliance (HIPAA) and deep integration into workflows. The company reports that its agents can resolve up to 85 % of routine patient interactions.
CEO and co-founder Israel Krush commented “After another 10 months of strong execution, landing new enterprise customers and expanding relationships with existing ones, we decided to bring on additional capital to further our mission of improving patient access to care and driving operational excellence for health systems.”
The funding round also signals growing investor confidence in healthcare-specific AI agents, especially as health systems grapple with staff shortages, demands for digital-first patient access and the need to free up clinician time. Hyro plans to further expand across specialties, segments and channels while maintaining safety, compliance and enterprise readiness.
“Healthcare is highly complex. What excites us about Hyro is their combination of advanced AI agents with deep healthcare-native design and safety mechanisms.”
By
HB Team
